Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. - Wikidata - awgldk - TriplyDB

Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

http://www.wikidata.org/entity/Q37083142

about

Control of sleep and wakefulness Unmet needs of patients with narcolepsy: perspectives on emerging treatment options Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice Update on the treatment of narcolepsy: clinical efficacy of pitolisant Genetic analysis of sleep.Histamine in the regulation of wakefulness.Histaminergic system in brain disorders: lessons from the translational approach and future perspectives.Narcolepsy with long sleep time: a specific entity?The histamine H3 receptor: from discovery to clinical trials with pitolisant Histamine Transmission Modulates the Phenotype of Murine Narcolepsy Caused by Orexin Neuron Deficiency.Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions Cerebrospinal Fluid Orexin A Levels and Autonomic Function in Kleine-Levin Syndrome.Animal models of narcolepsy.CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.Optogenetic Investigation of Arousal Circuits Challenges in the development of therapeutics for narcolepsy.Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases.Is suvorexant a better choice than alternative hypnotics?Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2.Is low histamine a fundamental cause of sleepiness in narcolepsy and idiopathic hypersomnia?Inability to replicate cerebrospinal fluid histamine deficits in the primary hypersomnias: a back to the drawing board moment.Histamine regulates activities of neurons in the ventrolateral preoptic nucleus.Histamine N-methyltransferase regulates aggression and the sleep-wake cycle.Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling.

P2860

Q24634619-5F06311C-FD5B-4CAE-992A-29B78F285E0F Q26827736-535C9463-8C7E-448F-80E9-DF716976479A Q30498843-AC4BAF61-F47B-4821-882D-16498098386D Q33631290-A11D6F79-304A-4035-A498-EF5C5F42FE15 Q33913163-6AC73C13-BD23-4112-93A1-5BF2335FED12 Q34138704-A2AAF131-6113-465C-865E-E2C38BE74322 Q34568925-884FCF3B-FAE3-45A4-B1AF-1F0EFE22724F Q34611827-72CB0387-2B2A-4D40-9E37-F049C1EE20A9 Q34629532-3B316950-918B-426C-A06D-7DE5C87A32C3 Q36170845-406DE2CA-D28D-4C52-93FC-DFD279E45715 Q36238099-6D95297E-447E-4347-BD88-137D5F6536D9 Q36686510-688D9148-F0F3-45C5-B607-28DB83556166 Q36764549-6A6064B8-8664-423B-9402-903FF1C7D915 Q37083146-6302234F-CC59-43EF-BEDC-EDFEA614D18C Q38642277-C475B3FE-AD77-4A27-983F-039E56654968 Q38684472-8EC1C5D7-5625-4FA2-A951-4A6A4CA3EB16 Q39622849-2AB5AE32-D1F4-4308-B708-ED93117C3F29 Q40900071-2C77EC09-53D5-4F07-9072-5DA7099BF1D6 Q42124350-2D044A1F-9FE2-4AC8-AC52-BC0874840565 Q42231718-5452A91C-95B4-4263-965F-8C83B5FCFA28 Q42325629-D4394435-A7B5-4A9F-ADC8-31DADF57D0CC Q42931958-70E0D7B1-F0F4-4A22-934F-D668997FF1FF Q47144278-4DD30656-B9AD-426E-BBDC-B96F8AED02FD Q49961724-9E47BC33-FCF2-4F06-B63F-3CD22A4BE967

P2860

Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

http://www.wikidata.org/entity/Q37083142

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Decreased CSF histamine in nar ...... omparison to healthy controls.

@en

Decreased CSF histamine in nar ...... omparison to healthy controls.

@nl

type

label

Decreased CSF histamine in nar ...... omparison to healthy controls.

@en

Decreased CSF histamine in nar ...... omparison to healthy controls.

@nl

prefLabel

Decreased CSF histamine in nar ...... omparison to healthy controls.

@en

Decreased CSF histamine in nar ...... omparison to healthy controls.

@nl

P1433

Q37083142-C5FA52B9-88E2-45C2-B52F-E7804B9F2310

P1476

Q37083142-2B954C67-4037-4400-A0A0-6272685D2627

P2093

Q37083142-4B3F40D7-D015-442B-BFAF-DC6F95AFE5A7

Q37083142-6D4399C2-18D4-448D-9396-5C7711B59ED2

Q37083142-A5DBE4F0-8C6C-490A-84B7-1A9EA66CF8DF

Q37083142-B35182B5-0B30-4087-B386-5BD739621484

Q37083142-DAE6A16E-9AB0-428B-A474-EFBC7ED8D2EC

Q37083142-DBB62589-80FF-4177-80B0-B6EF3E86BAC5

P2860

Q37083142-08ACCDCF-D9BB-4FD8-9ADD-94A75977F3C3

Q37083142-0AFAC046-5853-4470-8C93-86242A0C6E95

Q37083142-0F202B69-4D11-499B-8B54-32DFDFE2AF3E

Q37083142-1BA9877F-B90C-4F70-8CE1-E6AB5FB17E03

Q37083142-2EF32E8D-C151-4C12-AD5D-6C49BCD4AB75

Q37083142-352F9118-DA03-497A-BCDF-A7D769C478DE

Q37083142-3629C261-119D-4C9C-95AD-C0F273B5B49F

Q37083142-3A656632-1715-449D-8760-125F615573DC

Q37083142-3B773F5D-A2D0-484E-86F2-0F72AD13DE75

Q37083142-3C666122-BED0-4E00-A2A0-5E56B9303912

P304

Q37083142-698E2AE2-0AC0-4CCD-B835-5B4B8E2CDD2B

P31

Q37083142-965FF690-09EA-49B1-8EB3-438BA4405A07

P356

Q37083142-1514B8BE-B886-42C3-A7A4-F7C68935AE48

P433

Q37083142-2D97ED5A-17E2-4968-8F41-FA27A3BB52E1

P478

Q37083142-36C92DD6-917B-4ACA-A16B-2C67B670828F

P50

Q37083142-A5CA65BF-EFA6-443F-AC2E-6D9CCB569706

P577

Q37083142-BC1AD75F-6A06-48A1-9382-6B4462F20C72

P698

Q37083142-A7B3714F-0B3A-4A95-9632-78927E5D132A

P921

Q37083142-3A66DB98-BE9A-45C2-8B04-CEB67EE74258

P932

Q37083142-B393683E-E355-41D8-B606-EC0945B9AD3D

P356

P1433

P1476

Decreased CSF histamine in nar ...... comparison to healthy controls

@en

P2093

Eiko Sakurai

http://www.w3.org/2001/XMLSchema#string

Emmanuel Mignot

http://www.w3.org/2001/XMLSchema#string

Seiji Nishino

http://www.w3.org/2001/XMLSchema#string

Sona Nevsimalova

http://www.w3.org/2001/XMLSchema#string

Takehiko Watanabe

http://www.w3.org/2001/XMLSchema#string

Yasushi Yoshida

http://www.w3.org/2001/XMLSchema#string

P2860

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

The physiology of brain histamine.

Reduced number of hypocretin neurons in human narcolepsy.

Arousal effect of orexin A depends on activation of the histaminergic system.

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

Effects of lesions of the histaminergic tuberomammillary nucleus on spontaneous sleep in rats.

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

P304

175-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/SLEEP/32.2.175

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19238804

http://www.w3.org/2001/XMLSchema#string

P921

P932

2635581

http://www.w3.org/2001/XMLSchema#string